Calton & Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $440K | Buy |
|
|||||
|
2025
Q2 | $282K | Buy |
|
|||||
|
2025
Q1 | $281K | Buy |
|
|||||
|
2024
Q4 | $208K | Sell |
|
|||||
|
2024
Q3 | $258K | Sell |
|
|||||
|
2024
Q2 | $271K | Sell |
|
|||||
|
2024
Q1 | $363K | Sell |
|
|||||
|
2023
Q4 | $324K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $284K | Sell |
|
|||||
|
2023
Q1 | $295K | Buy |
|
|||||
|
2022
Q4 | $261K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $313K | Sell |
|
|||||
|
2022
Q1 | $323K | Sell |
|
|||||
|
2021
Q4 | $336K | Sell |
|
|||||
|
2021
Q3 | $314K | Sell |
|
|||||
|
2021
Q2 | $374K | Buy |
|
|||||
|
2021
Q1 | $333K | Buy |
|
|||||
|
2020
Q4 | $337K | Sell |
|
|||||
|
2020
Q3 | $396K | Sell |
|
|||||
|
2020
Q2 | $443K | Sell |
|
|||||
|
2020
Q1 | $448K | Buy |
|
|||||
|
2019
Q4 | $554K | Sell |
|
|||||
|
2019
Q3 | $536K | Sell |
|
|||||
|
2019
Q2 | $527K | Sell |
|
|||||
|
2019
Q1 | $618K | Buy |
|
|||||
|
2018
Q4 | $549K | Buy |
|
|||||
|
2018
Q3 | $439K | Buy |
|
|||||
|
2018
Q2 | $391K | Buy |
|
|||||
|
2018
Q1 | $300K | Sell |
|
|||||
|
2017
Q4 | $300K | Buy |
|